Cargando…
Oxaliplatin-induced Pulmonary Toxicity: A Rare but Serious Complication
The FOLFOX regimen (oxaliplatin, leucovorin, and 5-fluorouracil) is FDA approved for use in patients with colorectal cancer and other gastrointestinal malignancies. The initial phase III randomized controlled trials that led to FDA approval of oxaliplatin with leucovorin and 5-fluorouracil showed a...
Autores principales: | Suthar, Krishna H, Al Mutar, Salwan, Venkatesan, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188452/ https://www.ncbi.nlm.nih.gov/pubmed/32351861 http://dx.doi.org/10.7759/cureus.7483 |
Ejemplares similares
-
A Case of Gastric Emphysema: Incidental Findings or Serious Illness
por: Reyes, Jonathan Vincent, et al.
Publicado: (2020) -
Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
por: Eren, Tulay, et al.
Publicado: (2020) -
Colo-Fallopian Fistula: A Rare Complication of Sigmoid Colon Diverticulitis
por: Jones, Daemar H, et al.
Publicado: (2023) -
A Rare Complication of Feeding Jejunostomy: Murky Waters of the Surgeons
por: Chawla, Siddhi, et al.
Publicado: (2021) -
Complete Bilateral Ankle Fusion: A Rare Complication of Ankylosing Spondylitis
por: El-Fanek, Zaid, et al.
Publicado: (2022)